organization · Reporting owner
CFRS INVESTMENTS, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Innoveren Scientific, Inc.HCYT · Entity 95079 | 10% owner | March 21, 2022 | March 23, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Innoveren Scientific, Inc.
Report date March 21, 2022 · Filed March 23, 2022
Jointly reported with Lynch Frederick J
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | Indirect(SEE FOOTNOTE) | 8,321,785 |
Reported balance
After 2022-03-21 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2022-03-21 · Other · Acquired 8,321,785 · Balance 8,321,785 F1: Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein. |
| STOCK PURCHASE WARRANTSSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2030-09-24 | Indirect(SEE FOOTNOTE) | 17,886,434 |
Reported balance
After 2022-03-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-21 · Other · Disposed 8,321,785 · Balance 17,886,434 F2: Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing. F1: Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein. |
| STOCK PURCHASE WARRANTSSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2027-03-21 | Indirect(SEE FOOTNOTE) | 8,321,785 |
Reported balance
After 2022-03-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-21 · Other · Acquired 8,321,785 · Balance 8,321,785 F3: Represents five-year inducement warrants received from the issuer in connection with the exercise of the ten-year warrants. F1: Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
F2: Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing.
F3: Represents five-year inducement warrants received from the issuer in connection with the exercise of the ten-year warrants.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2022 Filed Mar 23, 2022 08:00 UTC | Innoveren Scientific, Inc. HCYT · Entity 95079 | OtherSTOCK PURCHASE WARRANTS · Derivative | 8,321,785 | $0.01 Strike: $0.01 | $116,504.99 |
DisclosureSEC source: 0001193805-22-000535 · e621483_4-lynch.xml · derivative · entry 3 Lynch Frederick J · CIK 0001580705 · 10% owner CFRS INVESTMENTS, LLC · CIK 0001912019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · (SEE FOOTNOTE) Disclosed balance after: 8,321,785 Underlying: COMMON STOCK · 8,321,785 shares Expires 2027-03-21 F3 · kind: Represents five-year inducement warrants received from the issuer in connection with the exercise of the ten-year warrants. F1 · ownership.nature: Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 08:00 UTC | Innoveren Scientific, Inc. HCYT · Entity 95079 | OtherSTOCK PURCHASE WARRANTS · Derivative | 8,321,785 | Not disclosed Strike: $0.01 | Not disclosed |
DisclosureSEC source: 0001193805-22-000535 · e621483_4-lynch.xml · derivative · entry 2 Lynch Frederick J · CIK 0001580705 · 10% owner CFRS INVESTMENTS, LLC · CIK 0001912019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · (SEE FOOTNOTE) Disclosed balance after: 17,886,434 Underlying: COMMON STOCK · 8,321,785 shares Expires 2030-09-24 F2 · price: Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing. F1 · ownership.nature: Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 08:00 UTC | Innoveren Scientific, Inc. HCYT · Entity 95079 | OtherCOMMON STOCK | 8,321,785 | $0.01 | $116,504.99 |
DisclosureSEC source: 0001193805-22-000535 · e621483_4-lynch.xml · nonDerivative · entry 1 Lynch Frederick J · CIK 0001580705 · 10% owner CFRS INVESTMENTS, LLC · CIK 0001912019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · (SEE FOOTNOTE) Disclosed balance after: 8,321,785 F1 · ownership.nature: Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.